Dr Reddy's Q1 Results
PSAI segment decline pulls down Dr Reddy's Q1 show
Earnings were driven by one-off gains
 "PSAI segment decline pulls down Dr Reddy's Q1 show")
Dr Reddy's Q1 net profit declines 53% to Rs 59 cr
BS ReporterHyderabad, 27 July: Indian generic pharmaceutical major Dr Reddy's Laboratories Limited has reported a 53 percent decline in net profit at Rs 59.1 crore for the quarter ended June, 2017 as the company's global generics revenues in the US fell 4 percent while there was a sharp 10 percent fall in India during the quarter.The company's net profit stood at Rs 126.3 crore in the year ago period.Revenues, including global generics and other verticals, grew 3 percent at Rs 3,315.9 crore in the quarter under review as compared with Rs 3234.5 crore in the corresponding quarter previous year. However, gross profit margin at 51.6 percent has declined by 460 basis points over that of the previous year. This was primarily on account of lower contribution from domestic formulations business consequent to GST transition and lower realisations in the company's North American generics business, the company said." Our first quarter results of FY 18 have been below expectations. While ...
 "Dr Reddy's Q1 net profit declines 53% to Rs 59 cr")
